Amgen To Buy Celgene’s Psoriasis Drug Otezla For $13.4 Billion In Cash | 10/21/2013 | Staff
trainman (Posted by) Level 3
(Reuters) – Amgen Inc said on Monday it would buy Celgene Corp’s psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene.

The deal for Otezla and certain related assets and...
(Excerpt) Read more at:
Wake Up To Breaking News!
Why do democrats never have to face the reality of what's on the ground, like 2000 years of marriage.
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!